Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
105.35
+0.36 (0.34%)
At close: Nov 13, 2026, 4:00 PM EST
106.15
+0.80 (0.76%)
After-hours: Nov 13, 2026, 7:30 PM EST
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $7.15 billion as of November 13, 2026. It is the 2,740th most valuable company in the world and the 929th biggest in the United States. Its market cap has increased by 421.55% in one year.
Market Cap
7.15B
Enterprise Value
5.94B
1-Year Change
421.55%
Global Rank
Country Rank
#929 United States
Category
ChartMarket Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $7.15B, an increase of 741.27%. That is a compound annual growth rate of 162.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 7.15B | 386.96% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.95B |
| Cytokinetics | 7.82B |
| Rhythm Pharmaceuticals | 7.62B |
| Axsome Therapeutics | 7.59B |
| Immunovant | 7.25B |
| Twist Bioscience | 7.16B |
| Caris Life Sciences | 6.87B |
| Belite Bio | 6.84B |